Tscan therapeutics to participate in the cowen 43rd annual health care conference

Waltham, mass., march 01, 2023 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that the company will participate in a panel discussion at the cowen 43rd annual health care conference being held at the boston marriott copley place in boston, ma on wednesday, march 8, 2023, at 2:10 p.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking